FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:567-579 February 8, 2007 Number 6 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Perspective by Doerschuk, C. M. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

ABSTRACT

Background Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte–macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in patients with pulmonary alveolar proteinosis and that GM-CSF autoantibodies cause the dysfunction.

Methods We studied 12 subjects with pulmonary alveolar proteinosis, 61 healthy control subjects, and 12 control subjects with either cystic fibrosis or end-stage liver disease. We also studied GM-CSF^–/– mice and wild-type mice. We evaluated basal neutrophil functions, neutrophil functions after priming by GM-CSF to augment antimicrobial functions, and the effects of highly purified GM-CSF autoantibodies on neutrophil functions in vitro and in vivo.

Results Neutrophils from subjects with pulmonary alveolar proteinosis had normal ultrastructure and differentiation markers but impaired basal functions and antimicrobial functions after GM-CSF priming. GM-CSF^–/– mice also had reduced basal neutrophil functions, but functions after GM-CSF priming were unimpaired. The neutrophil dysfunction characteristic of pulmonary alveolar proteinosis was reproduced in a dose-dependent fashion in blood specimens from healthy control subjects after incubation with affinity-purified GM-CSF autoantibodies isolated from patients with pulmonary alveolar proteinosis. The injection of mouse GM-CSF antibodies into wild-type mice also caused neutrophil dysfunction.

Conclusions The antimicrobial functions of neutrophils are impaired in patients with pulmonary alveolar proteinosis, owing to the presence of GM-CSF autoantibodies. The effects of these autoantibodies show that GM-CSF is an essential regulator of neutrophil functions.

Source Information

From the Divisions of Pulmonary Biology (K.U., T.Y., S.A., M.K.S., B.C.C., S.E.W., D.M.H., B.C.T.), Pulmonary Medicine (P.-Y.B., J.T.P., B.C.T.), Experimental Hematology (M.-D.F.), and Gastroenterology (L.A.D.), Cincinnati Children's Hospital Medical Center; and the Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine (D.C.B., J.T.P., B.C.T.) — both in Cincinnati.

Address reprint requests to Dr. Trapnell at the Division of Pulmonary Biology, Rm. 4029, TCHRF, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039, or at bruce.trapnell{at}cchmc.org.

Full Text of this Article

This article has been cited by other articles:

• Trapnell, B. C. (2009). A Novel Biomarker-guided Immunomodulatory Approach for the Therapy of Sepsis. Am. J. Respir. Crit. Care Med. 180: 585-586 [Full Text]  
• Serbina, N. V., Cherny, M., Shi, C., Bleau, S. A., Collins, N. H., Young, J. W., Pamer, E. G. (2009). Distinct Responses of Human Monocyte Subsets to Aspergillus fumigatus Conidia. J. Immunol. 183: 2678-2687 [Abstract] [Full Text]  
• Greenhill, S. R., Kotton, D. N. (2009). Pulmonary Alveolar Proteinosis: A Bench-to-Bedside Story of Granulocyte-Macrophage Colony-Stimulating Factor Dysfunction. Chest 136: 571-577 [Abstract] [Full Text]  
• Saha, S, Doe, C, Mistry, V, Siddiqui, S, Parker, D, Sleeman, M, Cohen, E S, Brightling, C E (2009). Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 64: 671-676 [Abstract] [Full Text]  
• Keilholz, U., Letsch, A., Busse, A., Asemissen, A. M., Bauer, S., Blau, I. W., Hofmann, W.-K., Uharek, L., Thiel, E., Scheibenbogen, C. (2009). A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. Blood 113: 6541-6548 [Abstract] [Full Text]  
• Wolters, P. J., Wray, C., Sutherland, R. E., Kim, S. S., Koff, J., Mao, Y., Frank, J. A. (2009). Neutrophil-Derived IL-6 Limits Alveolar Barrier Disruption in Experimental Ventilator-Induced Lung Injury. J. Immunol. 182: 8056-8062 [Abstract] [Full Text]  
• Borie, R., Debray, M-P., Laine, C., Aubier, M., Crestani, B. (2009). Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J 33: 1503-1506 [Abstract] [Full Text]  
• Uchida, K., Nakata, K., Suzuki, T., Luisetti, M., Watanabe, M., Koch, D. E., Stevens, C. A., Beck, D. C., Denson, L. A., Carey, B. C., Keicho, N., Krischer, J. P., Yamada, Y., Trapnell, B. C. (2009). Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113: 2547-2556 [Abstract] [Full Text]  
• Figueiredo, A. A, Brandao, G., Dentz, L. C, Alves, C. M M, Stroppa, A. E S (2009). Bilateral pulmonary alveolar infiltrate and prostate tumour in a 54-year-old man. BMJ Case Reports 2009: bcr0920080888-bcr0920080888 [Abstract] [Full Text]  
• Lin, F.-C., Chen, Y.-C., Chang, S.-C. (2008). Clinical Importance of Bronchoalveolar Lavage Fluid and Blood Cytokines, Surfactant Protein D, and Kerbs von Lungren 6 Antigen in Idiopathic Pulmonary Alveolar Proteinosis. Mayo Clin Proc. 83: 1344-1349 [Abstract] [Full Text]  
• Martinez-Moczygemba, M., Doan, M. L., Elidemir, O., Fan, L. L., Cheung, S. W., Lei, J. T., Moore, J. P., Tavana, G., Lewis, L. R., Zhu, Y., Muzny, D. M., Gibbs, R. A., Huston, D. P. (2008). Pulmonary alveolar proteinosis caused by deletion of the GM-CSFR{alpha} gene in the X chromosome pseudoautosomal region 1. JEM 205: 2711-2716 [Abstract] [Full Text]  
• Suzuki, T., Sakagami, T., Rubin, B. K., Nogee, L. M., Wood, R. E., Zimmerman, S. L., Smolarek, T., Dishop, M. K., Wert, S. E., Whitsett, J. A., Grabowski, G., Carey, B. C., Stevens, C., van der Loo, J. C.M., Trapnell, B. C. (2008). Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. JEM 205: 2703-2710 [Abstract] [Full Text]  
• Notarangelo, L. D., Pessach, I. (2008). Out of breath: GM-CSFR{alpha} mutations disrupt surfactant homeostasis. JEM 205: 2693-2697 [Abstract] [Full Text]  
• Woischnik, M., Bauer, A., Aboutaam, R., Pamir, A., Stanzel, F., de Blic, J., Griese, M. (2008). Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis. Eur Respir J 31: 1197-1204 [Abstract] [Full Text]  
• Frazier, A. A., Franks, T. J., Cooke, E. O., Mohammed, T.-L. H., Pugatch, R. D., Galvin, J. R. (2008). From the Archives of the AFIP: Pulmonary Alveolar Proteinosis. RadioGraphics 28: 883-899 [Abstract] [Full Text]  
• Inoue, Y., Trapnell, B. C., Tazawa, R., Arai, T., Takada, T., Hizawa, N., Kasahara, Y., Tatsumi, K., Hojo, M., Ichiwata, T., Tanaka, N., Yamaguchi, E., Eda, R., Oishi, K., Tsuchihashi, Y., Kaneko, C., Nukiwa, T., Sakatani, M., Krischer, J. P., Nakata, K., for the Japanese Center of the Rare Lung Diseases, (2008). Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan. Am. J. Respir. Crit. Care Med. 177: 752-762 [Abstract] [Full Text]  
• (2007). Answer. Thorax 62: 1018-1018 [Full Text]  
• (2007). . Vet Pathol 44: 556-557 [Full Text]  
• Bendtzen, K., Svenson, M., Hansen, M. B., Busch, T., Bercker, S., Kaisers, U., Uchida, K., Beck, D. C., Trapnell, B. C. (2007). GM-CSF Autoantibodies in Pulmonary Alveolar Proteinosis. NEJM 356: 2001-2002 [Full Text]  
• Mukherjee, S. (2007). Pulmonary alveolar proteinosis: revealing a wider defect in host immunity. Thorax 62: 402-402 [Full Text]